These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11376459)

  • 21. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
    Coppen A; Bailey J
    J Affect Disord; 2000 Nov; 60(2):121-30. PubMed ID: 10967371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
    Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
    Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
    Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients.
    Mentré F; Golmard JL; Launay JM; Aubin-Brunet V; Bouhassira M; Jouvent R
    Psychiatry Res; 1998 Dec; 81(3):403-5. PubMed ID: 9925192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression.
    Heiligenstein JH; Ware JE; Beusterien KM; Roback PJ; Andrejasich C; Tollefson GD
    Int Psychogeriatr; 1995; 7 Suppl():125-37. PubMed ID: 8580388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
    Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group.
    Schneider LS; Small GW; Hamilton SH; Bystritsky A; Nemeroff CB; Meyers BS
    Am J Geriatr Psychiatry; 1997; 5(2):97-106. PubMed ID: 9106373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
    Cassano P; Soares CN; Cusin C; Mascarini A; Cohen LS; Fava M
    Psychother Psychosom; 2005; 74(6):362-5. PubMed ID: 16244512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent classes of nonresponders, rapid responders, and gradual responders in depressed outpatients receiving antidepressant medication and psychotherapy.
    Thibodeau MA; Quilty LC; De Fruyt F; De Bolle M; Rouillon F; Bagby RM
    Depress Anxiety; 2015 Mar; 32(3):213-20. PubMed ID: 25069431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a case-control study.
    Xiang YT; Wong TS; Tsoh J; Ungvari GS; Correll CU; Sareen J; Penner-Goeke K; Ko FW; Hui DS; Chiu HF
    Perspect Psychiatr Care; 2015 Apr; 51(2):121-7. PubMed ID: 24890904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
    Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
    J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial.
    Stevens T; Katona C; Manela M; Watkin V; Livingston G
    Int J Geriatr Psychiatry; 1999 Jun; 14(6):467-72. PubMed ID: 10398357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
    Lin CH; Yen YC; Chen MC; Chen CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
    Ferreri M; Lavergne F; Berlin I; Payan C; Puech AJ
    Acta Psychiatr Scand; 2001 Jan; 103(1):66-72. PubMed ID: 11202131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality predictors in disabling chronic obstructive pulmonary disease in old age.
    Yohannes AM; Baldwin RC; Connolly M
    Age Ageing; 2002 Mar; 31(2):137-40. PubMed ID: 11937477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.